Clover Biopharmaceuticals, Ltd. a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that they have entered into a long-term...
Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology...
RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...
Astellas Pharma Inc. and Dyno Therapeutics, Inc. announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV)...
Lunit, a leading medical AI provider, announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company's planned public offering on...
